R. Chegeni

发表

Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study.

M. Bandehpour, B. Kazemi, N. Mosaffa, 2020, Human immunology.

Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate

N. Saki, M. Shokouhian, R. Chegeni, 2020, Journal of cellular physiology.

Inhibition of Skp2 enhances doxorubicin‐induced cell death in B cell precursor acute lymphoblastic leukemia

M. Safa, F. Zaker, Mohammad Faranoush, 2022, Cell biology international.

Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae

M. Bandehpour, H. Ghanbarian, B. Kazemi, 2020, International Journal of Peptide Research and Therapeutics.

Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells

M. Ozelo, M. Othman, D. Lillicrap, 2008, Journal of thrombosis and haemostasis : JTH.

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.

P. Thompson, D. Lillicrap, C. Hough, 2009, Blood.

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 (cid:1) CD25 (cid:1) -dependent mechanism and by shifting cytokine production to favor a Th1 response

P. Thompson, D. Lillicrap, C. Hough, 2008 .

cytokine production to favor a Th 1 response-dependent mechanism and by shifting + CD 25 + by a regulatory CD 4 Anti-CD 3 prevents factor VIII inhibitor development in hemophilia A mice

P. Thompson, D. Lillicrap, C. Hough, 2008 .

Heart Diseases Associated Genes

M. Bandehpour, B. Kazemi, Shivasadat Gheflat, 2020 .

Immunoglobulin isotypes and functional anti‐FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice

M. Othman, D. Lillicrap, C. Hough, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Coagulation Factor V Mutations in Iranian Patients with Venous Thrombosis

A. Hajifathali, B. Kazemi, A. Pourfathollah, 2005 .

Detection of the Factor V Leiden Mutation in Iranian Patients with Venous Thrombosis

Y. Mehrabi, A. Hajifathali, B. Kazemi, 2005 .

Molecular genetic testing of hemostasis and thrombosis in developing countries: achievements, hopes, and challenges.

M. Ozelo, M. Othman, M. Qadura, 2008, Seminars in Thrombosis and Hemostasis.

Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.

A. Hajifathali, B. Kazemi, A. Pourfathollah, 2007, Thrombosis research.

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

M. Othman, D. Lillicrap, C. Hough, 2009, Blood.

The Cytotoxic and Antileishmanial Effects of Satureja khuzestanica Essential Oil

B. Delfan, M. Rashidipour, F. Ebrahimzadeh, 2016 .

Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies.

A. Hajifathali, E. Roshandel, M. Salimi, 2020, Immunology letters.

Immune checkpoints in hematologic malignancies: What made the immune cells and clinicians exhausted!

A. Hajifathali, E. Roshandel, M. Kazemi, 2020, Journal of cellular physiology.

Evaluation of H3 histone methylation and colony formation in erythroid progenitors treated with thalidomide and sodium butyrate.

M. Soleimani, M. Ahmadvand, N. Saki, 2013, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

Involvement of classic and alternative non-homologous end joining pathways in hematologic malignancies: targeting strategies for treatment

M. Safa, S. Ahmadi, R. Chegeni, 2021, Experimental Hematology & Oncology.

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

M. Safa, S. Ahmadi, R. Chegeni, 2021, Journal of Hematology & Oncology.

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease

A. Hajifathali, E. Roshandel, M. Kazemi, 2020, Medical journal of the Islamic Republic of Iran.

Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation.

A. Hajifathali, E. Roshandel, S. Parkhideh, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Functional analysis of three recombinant A1-VWF domain mutants in comparison to wild type and plasma-derived VWF facilitates subtyping in type 2 von Willebrand disease.

M. Othman, D. Lillicrap, E. Favaloro, 2011, Thrombosis research.

Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae

M. Bandehpour, H. Ghanbarian, B. Kazemi, 2020, International Journal of Peptide Research and Therapeutics.

Human von Willebrand Disease Mutations in Mouse von Willebrand Factor Alter Its Cleavage by ADAMTS13.

D. Lillicrap, C. Notley, C. Hegadorn, 2007 .

Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR

M. Safa, F. Zaker, R. Chegeni, 2023, Molecular Biology Reports.

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

M. Othman, D. Lillicrap, C. Hough, 2009, Blood.

Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells

C. Hough, A. Labelle, R. Chegeni, 2008, Journal of thrombosis and haemostasis : JTH.